Administration Can’t Be Trusted With Generic User Fees, Rep. Waxman Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Rep. Henry Waxman (D-Calif.) is opposing possible user fees for generic drug applications, arguing that the societal benefit of rapid generic entry justifies increased appropriations for the office